ArticleJournal for immunotherapy of cancer2019

Therapeutic efficacy of a novel humanized antibody-drug conjugate recognizing plexin-semaphorin-integrin domain in the RON receptor for targeted cancer therapy.

Xiang-Min Tong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.